Healthcare utilization and costs in children with stable and uncontrolled epilepsy
- PMID: 24561658
- DOI: 10.1016/j.yebeh.2014.01.016
Healthcare utilization and costs in children with stable and uncontrolled epilepsy
Abstract
Objective: Epilepsy adversely affects childhood development, possibly leading to increased economic burden in pediatric populations. We compared annual healthcare utilization and costs between children (<12 years old) with stable and uncontrolled epilepsy treated with antiepileptic drugs (AEDs).
Methods: Children (<12 years old) with epilepsy (ICD-9-CM 345.xx or 780.39) in 2008 were identified in the MarketScan claims database from 2007 to 2009. Patients with "stable" epilepsy used the same AED for ≥12 months, and patients with "uncontrolled" epilepsy were prescribed additional AED(s) during that period. For patients with uncontrolled epilepsy, the study index date was the start of additional AED(s); for patients with stable epilepsy, the study index date was a random AED fill date. Epilepsy-related utilization included medical services with 345.xx or 780.39 in any diagnosis field and AED fills. Epilepsy-related costs included AEDs, medical claims with epilepsy in any diagnosis field, and certain tests. We adjusted for baseline cohort differences (demographics, region, usual-care physician specialty, and comorbidities) using logistic regression and analysis of covariance.
Results: Two thousand one hundred seventy patients were identified (mean: 7.5 years; 45.3% were female; Charlson comorbidity index: 0.3; 422 (19.4%) patients with uncontrolled epilepsy). Patients with uncontrolled epilepsy faced more hospitalizations (30.1% vs. 12.0%) and greater overall ($30,343 vs. $18,206) and epilepsy-related costs ($16,894 vs. $7979) (all p<.001). Adjusting for baseline measures, patients with uncontrolled epilepsy had greater odds of hospitalization (OR: 2.5; 95% CI: 1.9-3.3) and costs (overall: $3908, p=.087; epilepsy-related: $5744, p<.001).
Conclusions: Children with uncontrolled epilepsy use significantly more healthcare resources and have a greater economic burden than children with stable epilepsy. However, epilepsy accounted for only half of overall costs, indicating that comorbid conditions may add substantially to the disease burden.
Keywords: Antiepileptic drugs; Children; Comorbidities; Cost analysis; Economics; Epilepsy; Medical care; Pediatric epilepsy; Seizures.
Copyright © 2014 Elsevier Inc. All rights reserved.
Similar articles
-
Health-care costs and utilization related to long- or short-acting antiepileptic monotherapy use.Epilepsy Behav. 2015 Mar;44:40-6. doi: 10.1016/j.yebeh.2014.12.020. Epub 2015 Jan 27. Epilepsy Behav. 2015. PMID: 25635369
-
Healthcare utilization and costs in adults with stable and uncontrolled epilepsy.Epilepsy Behav. 2014 Feb;31:356-62. doi: 10.1016/j.yebeh.2013.09.046. Epub 2013 Nov 12. Epilepsy Behav. 2014. PMID: 24239435
-
Burden of uncontrolled epilepsy in patients requiring an emergency room visit or hospitalization.Neurology. 2012 Oct 30;79(18):1908-16. doi: 10.1212/WNL.0b013e318271f77e. Epub 2012 Oct 17. Neurology. 2012. PMID: 23077014
-
A review of the costs of managing childhood epilepsy.Pharmacoeconomics. 2005;23(1):27-45. doi: 10.2165/00019053-200523010-00003. Pharmacoeconomics. 2005. PMID: 15693726 Review.
-
Comprehensive care of the epilepsy patient--control, comorbidity, and cost.Epilepsia. 2004;45 Suppl 6:3-12. doi: 10.1111/j.0013-9580.2004.455002.x. Epilepsia. 2004. PMID: 15315510 Review.
Cited by
-
Cost-effectiveness of ambroxol in the treatment of Gaucher disease type 2.Open Med (Wars). 2024 May 21;19(1):20240970. doi: 10.1515/med-2024-0970. eCollection 2024. Open Med (Wars). 2024. PMID: 38799251 Free PMC article.
-
Early genetic testing in pediatric epilepsy: Diagnostic and cost implications.Epilepsia Open. 2024 Feb;9(1):439-444. doi: 10.1002/epi4.12878. Epub 2023 Dec 16. Epilepsia Open. 2024. PMID: 38071479 Free PMC article.
-
Hospital readmissions in children with new-onset infantile epileptic spasms syndrome.Epilepsia Open. 2023 Jun;8(2):444-455. doi: 10.1002/epi4.12711. Epub 2023 Mar 30. Epilepsia Open. 2023. PMID: 36790214 Free PMC article.
-
Implications of Seizure-Cluster Treatment on Healthcare Utilization: Use of Approved Rescue Medications.Neuropsychiatr Dis Treat. 2022 Oct 25;18:2431-2441. doi: 10.2147/NDT.S376104. eCollection 2022. Neuropsychiatr Dis Treat. 2022. PMID: 36325434 Free PMC article. Review.
-
Cost-effectiveness of perampanel as an adjunctive treatment for uncontrolled focal seizures in pediatric patients: a Chinese perspective.Ann Transl Med. 2022 Mar;10(6):364. doi: 10.21037/atm-22-994. Ann Transl Med. 2022. PMID: 35433936 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical